drugset / Trial / NCT07626515
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase I, randomized, double-blinded, placebo-controlled, study to assess the safety, tolerability, and pharmacokinetics (PK) of enicepatide in generally healthy adult Chinese participants with body mass index (BMI) ≥23.0 kilograms per meter squared (kg/m\^2).
Timeline
- Start
- 2026-07-02
- Primary completion
- 2027-04-30
- Completion
- 2027-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enicepatide | Unknown | — | Subcutaneous |
Indications
No indication recorded.